4.36
전일 마감가:
$4.32
열려 있는:
$4.31
하루 거래량:
321.42K
Relative Volume:
0.12
시가총액:
$77.01M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-2.8129
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
+4.06%
1개월 성능:
+3.56%
6개월 성능:
+676.35%
1년 성능:
+1,134%
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
명칭
Unicycive Therapeutics Inc
전화
650-384-0642
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
UNCY
Unicycive Therapeutics Inc
|
4.36 | 76.30M | 0 | -30.54M | -18.30M | -1.55 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-21 | 개시 | Guggenheim | Buy |
2024-04-04 | 개시 | Piper Sandler | Overweight |
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Is Unicycive Therapeutics Inc. stock entering bullish territoryLong Setup & Risk Adjusted Swing Trade Ideas - Newser
Unicycive Therapeutics' Securities Lawsuit: Strategic Investor Considerations Amid Regulatory and Legal Challenges - AInvest
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - FinancialContent
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - MarketScreener
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Unicycive Therapeutics, Inc. (UNCY) | FinancialContent - FinancialContent
The Risks of Over-Optimism in Telecommunications: A Case Study of Unicycive Therapeutics and Charter Communications Class-Action Allegations - AInvest
UNCY Investors: If you Lost Significant Money in UNCY Contact Robbins LLP for Information About the Securities Fraud Class Action Against Unicycive Therapeutics, Inc. - PR Newswire
Unicycive Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky ... - Bluefield Daily Telegraph
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (UNCY) to a Class Action Deadline on October 14, 2025 - FinancialContent
Tools to monitor Unicycive Therapeutics Inc. recovery probabilityWeekly Profit Summary & Daily Risk Controlled Trade Plans - Newser
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 14, 2025 in Unicycive Therapeutics, Inc. LawsuitUNCY - WV News
What indicators show strength in Unicycive Therapeutics Inc.2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
Unicycive Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Risk adjusted return profile for Unicycive Therapeutics Inc. analyzed2025 Analyst Calls & AI Enhanced Execution Alerts - Newser
Custom watchlist performance reports with Unicycive Therapeutics Inc.Swing Trade & Free Risk Controlled Daily Trade Plans - Newser
Is Unicycive Therapeutics Inc. impacted by rising ratesOil Prices & Long-Term Safe Return Strategies - خودرو بانک
Securities Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Earnings visualization tools for Unicycive Therapeutics Inc.July 2025 Market Mood & Reliable Entry Point Alerts - Newser
Investors SueWallSt Over Unicycive Therapeutics, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Is Unicycive Therapeutics Inc. stock good for income investorsJuly 2025 Macro Moves & AI Enhanced Trading Alerts - خودرو بانک
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - FinancialContent
Join Class Action to Recover Losses from Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
What MACD and RSI say about Unicycive Therapeutics Inc.2025 Price Targets & Verified Chart Pattern Signals - Newser
Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile
Shareholders of Unicycive Therapeutics, Inc. (UNCY): Protect Your Rights Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
What candlestick patterns are forming on Unicycive Therapeutics Inc.Trade Entry Report & Expert Curated Trade Setup Alerts - Newser
Risk vs reward if holding onto Unicycive Therapeutics Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
Will Unicycive Therapeutics Inc. stock recover after recent dropWeekly Gains Summary & Consistent Profit Focused Trading Strategies - Newser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Unicycive Therapeutics - Menafn.com
Is this a good reentry point in Unicycive Therapeutics Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser
How to monitor Unicycive Therapeutics Inc. with trend dashboardsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky to Join Class Action Before October 14, 2025 - ACCESS Newswire
Can Unicycive Therapeutics Inc. weather a recessionJuly 2025 Action & Accurate Buy Signal Alerts - khodrobank.com
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will Unicycive Therapeutics Inc. face regulatory challengesRecession Risk & Real-Time Buy Zone Alerts - خودرو بانک
Does Unicycive Therapeutics Inc. have declining or rising EPSJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - khodrobank.com
Can machine learning forecast Unicycive Therapeutics Inc. recovery2025 Macro Impact & Weekly Momentum Stock Picks - Newser
Will Unicycive Therapeutics Inc. stock go up in YEARTrade Risk Assessment & AI Forecasted Stock Moves - خودرو بانک
Aug Closing: Is Unicycive Therapeutics Inc. impacted by rising ratesWeekly Trend Recap & Risk Controlled Daily Plans - khodrobank.com
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
How hedge fund analytics apply to Unicycive Therapeutics Inc. stockWeekly Market Report & Community Consensus Picks - Newser
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Why Unicycive Therapeutics Inc. stock attracts strong analyst attention2025 Big Picture & Low Risk High Reward Trade Ideas - beatles.ru
Securities Fraud Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Reminds Investors of October 14, 2025 - ACCESS Newswire
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Shareholders of Class Action Lawsuit and October 14, 2025 Deadline - ACCESS Newswire
Quant Strategy Flags Unicycive Therapeutics Inc. for Entry getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Unicycive Therapeutics Inc. in Accumulation Phase Now getLinesFromResByArray error: size == 0 - 뉴스영
Is Unicycive Therapeutics Inc. stock reversal real or fakeQuarterly Performance Summary & Community Verified Watchlist Alerts - Newser
Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline October 14, 2025 - ACCESS Newswire
Unicycive Therapeutics Inc (UNCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):